ABVC — ABVC Biopharma Share News
0.000.00%
U.S. STOCKS ON THE MOVE-O'Reilly Automotive, Mattel, Amazon
U.S. STOCKS ON THE MOVE-Exxon Mobil, Harley-Davidson, Sunnova Energy
U.S. STOCKS ON THE MOVE-ServiceNow, Kenvue, Forward Air
Brief: ABVC Biopharma Enters Into Term Sheet To License Global Rights Of CNS Drugs with Indications of MDD and ADHD To AiBtl Biopharma
Brief: ABVC BioPharma Announces Completion Of Subject Recruitment For Interim Analysis On ADHD Phase IIb Clinical Study
Brief: Abvc Biopharma Receives Taiwanese Patent For Its Treatment Of Major Depressive Disorder
Brief: Abvc Biopharma Believes Has Regained Compliance With Stockholders' Equity Requirement
Brief: Abvc Biopharma Provides Updates On Adhd Phase Iib Clinical Study
Brief: Abvc Executes Cooperation Agreement For Strategic Investments
Brief: Abvc Biopharma Executes Cooperation Agreement For Strategic Investments
Brief: ABVC Biopharma Got Letter From Nasdaq
Brief: ABVC Announces Approval Of Plan For GMP Production Facilities
U.S. STOCKS ON THE MOVE-Marriott, Advanced Micro Devices, Leidos Holdings
U.S. STOCKS ON THE MOVE-SiriusXM, ABVC Biopharma, Altria
ABVC Biopharma shares jump on drug license deal
Brief: ABVC Biopharma Announces Pricing Of $1.75 Mln Registered Direct Offering
Brief: ABVC Biopharma Announces Pricing Of $1.75 Million Offering
Brief: ABVC Signs Term Sheet To Acquire Real Estate Assets
Brief: Abvc Biopharma Says Nasdaq Granted Co An Extension To Comply With A Listing Rule